Renny is currently interim CEO of the Eastern Academic Health Sciences Network (AHSN) based at Addenbrooke’s Hospital in Cambridge. Prior to that he founded the South West AHSN across Devon Somerset and Cornwall working in partnership with the academic, NHS, commercial and voluntary sectors. The AHSN network was established in England with government funding to identify and adopt innovation that will impact on health and wealth opportunities. Renny has been senior independent director of one of the top performing NHS Foundation Trusts in England, a member of the clinical research panel for the UK’s Research Excellence Framework and is also chairman of Lord Snowdon’s Award Scheme for disabled students. He was previously CEO of a venture capital backed Clinical Research Organisation and Director of Clinical Research at the Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust. Renny has a DPhil. in peptide and hormone biochemistry and represents one of Isogenica’s major shareholders.